|
FAM167B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.36100020142749E-10 |
| Normal-vs-Stage3 |
1.91950011441122E-10 |
| Normal-vs-Stage4 |
1.777090E-04 |
| Stage1-vs-Stage2 |
1.755770E-02 |
| Stage1-vs-Stage3 |
1.94779999995731E-06 |
| Stage1-vs-Stage4 |
3.022700E-03 |
| Stage2-vs-Stage3 |
1.84733999999409E-05 |
| Stage2-vs-Stage4 |
4.44339999999821E-05 |
| Stage3-vs-Stage4 |
8.378600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.244750E-03 |
| Normal-vs-Asian |
2.05710000034109E-07 |
| Caucasian-vs-AfricanAmerican |
5.929600E-01 |
| Caucasian-vs-Asian |
2.698000E-01 |
| AfricanAmerican-vs-Asian |
2.699800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66144875635155E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
2.226800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.60120028347421E-10 |
| Normal-vs-Age(81-100Yrs) |
1.284420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.501380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.099020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.176760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.120000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.859610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.034400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.27890000004116E-06 |
| Classical-VS-Follicular |
2.91049999989745E-07 |
| Classical-VS-Other |
7.691900E-02 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.23154827949656E-13 |
| Tall-VS-Other |
3.893800E-01 |
| Tall-VS-Normal |
4.498000E-02 |
| Follicular-VS-Other |
1.023230E-04 |
| Follicular-VS-Normal |
<1E-12 |
| Other-VS-Normal |
2.697500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.68539999956252E-07 |
| N0-vs-N1 |
4.595400E-03 |
|
|
